Trials / Completed
CompletedNCT06267326
World Health Organization (WHO) , COVID19 Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt
Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Nasser Institute For Research and Treatment · Other Government
- Sex
- All
- Age
- 22 Years – 77 Years
- Healthy volunteers
- Accepted
Summary
Objectives: identify and recognize clinical Characteristics, Pathophysiology, and management of a group of patients with rhino Rhino-Orbito-Cerebral Mucormycosis infection associated with Covid 19 viral infection
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | debridment | resection of dead bone |
Timeline
- Start date
- 2021-05-23
- Primary completion
- 2022-06-12
- Completion
- 2023-08-21
- First posted
- 2024-02-20
- Last updated
- 2024-02-20
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06267326. Inclusion in this directory is not an endorsement.